Related Experiment Videos

Transformation and transactivation suppressor activity of the c-Jun leucine zipper fused to a bacterial repressor

M Granger-Schnarr1, E Benusiglio, M Schnarr

  • 1Institut de Biologie Moléculaire et Cellulaire du Centre Nationale de la Recherche Scientifique, Strasbourg, France.

Insights

The Ras-induced signal transduction pathway involves transcription factor AP-1. Researchers found that interfering with transcription factor dimerization can suppress Ras-mediated cell transformation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Ras-induced signal transduction pathway is crucial in cellular processes.
  • Transcription factor c-Jun is a known nuclear target of this pathway.
  • The precise role of c-Jun in Ras-mediated cellular transformation remains unclear.

Purpose of the Study:

  • To investigate the role of c-Jun dimerization in Ras-mediated cellular transformation.
  • To determine if interfering with transcription factor dimerization can inhibit transformation.

Main Methods:

  • Utilized a LexA-Jun zipper fusion protein lacking transcriptional activation and DNA-binding domains.
  • Assessed the dominant-negative effect of the fusion protein on AP-1-responsive transcriptional activation.
  • Evaluated the fusion protein's ability to suppress transformation in ras-transformed cells.

Main Results:

  • The LexA-Jun zipper fusion protein exhibited a dominant-negative effect on transcriptional activation induced by various factors, including Ras.
  • The fusion protein suppressed cellular transformation, leading to the generation of non-transformed revertants.
  • These effects were attributed to the leucine-zipper domain's ability to trap transcription factors, preventing DNA binding.

Conclusions:

  • Ras-mediated cellular transformation critically involves the functional transcription factor AP-1.
  • Interfering with the dimerization of transcription factors is a viable strategy to inhibit cell transformation.
  • Targeting transcription factor dimerization offers a potential therapeutic approach for cancers driven by Ras signaling.

Related Concept Videos